References
- Negrin R, Storb R, Forman S. Bone marrow transplantation in malignant disease. The American Society of Hematology Education Program Book. Hematology, JR Me Arthur, GP Schechter, SL Schrier, WashingtonUSA 1998; 342–-370
- Giralt S, Estey E, Albitar M, van Besien K, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeoablative therapy. Blood 1997; 89: 4531–4536
- Slavin S, Nagler A, Naparstek E, Kapelushnik Y, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoredoction for the treatment of malignant and nonmalignant hematological diseases. Blood 1998; 91: 756–763
- Carella A M, Lerma E, Dejana A, Corsetti M T, Celesti L, Bruni R, Benvenuto F, Figari O, Parodi C, Carlier P, Florio G, Lercari G, Valbonesi M, Casarino L, De Stefano F, Geniram A, Venturino M, Tedeschi L, Palmieri G, Piaggio G, Podesta M, Frassoni F, van Lint M T, Marmont A M, Bacigalupo A. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with bematologic neoplasias. Haematologica 1998; 83: 904–909
- McSweeney P, Niederweiser D, Shizuru J, Molina A, Wagner J, Minor S, Radich J, Chauncey T, Hegenbart U, Maloney D, Nash R, Sandmaier B, Blume K, Storb R. Outpatient allografting with minimally myelosuppressive, immunosuppressive conditioning of low-dose TBI and post-grafting cyclosporine and mycophenolate mofetil. Blood 1999; 94: 393a, (Suppl 1)
- Sandmaier B M, McSweeney P, Cong Yu, Storb R. Nonmyeloablative transplants: Preclinical and clinical results. Sem Oncol 2000; 27: 78–81, (Suppl 5)
- Gómez-Almaguer D, Ruiz-Argüelles GJ, Ruiz-Argüelles A, González-Llano O, Cantú OE, Hernández NE. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis. Bone Marrow Transpl 2000; 25: 131–133
- Ruiz-Argüelles GJ, Gómez-Almaguer D, González-Llano O, Cantú OE. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen are less costly and can be safely performed on an outpatient basis. Int J Hematol 2000; 72: 57–-58, (Suppl 1)
- Bender J G, To L B, Williams S F, Schwartzberg L. Defining a therapuetic dose of peripheral blood stem cells. J Hematother 1992; 1: 329–341
- Gee A P. Collection and processing of peripheral blood hematopoietic progenitor cells. Martin Dunitz Limited. Blood Stem Cell Transplantation, J Reiffers, JM Goldman, JO Armitage, London 1998; 55–-72
- van der Wall E, Richel D J, Holtkamp M J. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood cell transplantation: Effect of graft size. Ann Oncol 1994; 5: 795–802
- Kessinger A, Armitage J O, Landmark J D, Smith D M, Weisenburger D D. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1998; 71: 723–727
- Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Delgado-Lamas J L. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol 1998; 58: 161–164
- Ruiz-Argüelles A. Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992; 50: 735–743
- Ruiz-Argüelles A, Orfao A. Caracterización y evaluación de céluias totipotenciales en sangre periférica y médula ósea. Editorial Médico Panamericana. Actualization en Leucemias, GJ Ruiz-Argüelles, J.F San-Miguel, México City 1996; 79–-82
- Pinkel D, Straume T, Gray J W. Cytogenetic analysis using quantitative, high sensitivity fluorescence hybridization. Proc Natl Acad Sci USA 1996; 2934–-2938
- Yam P, Petz L, Knowlton R, Wallace R, Stock A, de Lange G, Brown V, Doris-Keller H, Blume K G. Use of DNA restriction fragment length polymorphisms to document marrow engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 1987; 43: 399–407
- Olweus J, Lund-Johanson F, Terstapen LWMM. Expression of cell surface markers during differentiation of CD34+, CD38-/lo fetal and adult bone marrow cells. Immunomethods 1995; 5: 179–188
- Tricot G, Jagganath S, Vesole D. Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 22 patients. Blood 1995; 85: 588–596